Medical devices, healthcare technology and the business of care
510(k) clearance · K260997

SIS BLU (SISBLU-30-01);SIS BLU (SISBLU-15-01)

Endoclot Plus Co., Ltd. · Decision date Sep 9, 2026

MEDTECHLEDGER EXPLANATIONK260997

What did the FDA decide?

FDA recorded decision SESE for premarket notification K260997, dated 2026-09-09, covering the devices SIS BLU (SISBLU-30-01) and SIS BLU (SISBLU-15-01), submitted by Endoclot Plus Co., Ltd. of Suzhou, China. The record lists the medical specialty as Gastroenterology, Urology and product code PLL. In 510(k) practice, SESE denotes a substantially equivalent determination, meaning clearance to market rather than premarket approval of a new device.

The two model numbers indicate a device family submitted under one application, but the source record does not describe the device's composition, mechanism, intended use, or what distinguishes the 30-01 and 15-01 versions. No summary statement is present, and no predicate device, review timeline, or clinical evidence appears in the available data. The listed contact is Huihui Xie. Details of indications, patient selection, and use instructions would reside in the underlying FDA documents, which were not available here.

Readers should treat this as a clearance record only. The absence of a summary statement and device description limits any assessment of the technology or its regulatory basis, and no conclusion about safety or effectiveness can be drawn from the fields shown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 9, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260997
Regulatory pathway
510(k) premarket notification
Product code
PLL
Decision code
SESE
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Submucosal Injection Agent.

Product code
PLL
FDA device class
2

FDA decision timeline

  1. K260997 received

    Application receipt date recorded by FDA.

  2. K260997 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Endoclot Plus Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Suzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records